New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented INmune Bio Inc. (NASDAQ: INMB), in the Company’s Initial Public Offering and subsequent listing on the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Marc Ross and partners David Manno and Thomas Rose. The stock became effective for trading on February 4, 2019, and its common stock trades under the symbol, “INMB.”
Follow Sichenzia Ross Ference on Twitter: @SichenziaRoss
